Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer

Details for Australian Patent Application No. 2006337085 (hide)

International Classifications

Event Publications

15 January 2009 Section 223 Application Allowed

Genentech, Inc.; Curis, Inc. The time in which to enter the national phase has been extended to 27 Aug 2008. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000 2007

29 January 2009 PCT application entered the National Phase

PCT publication WO2007/089367 Priority application(s): WO2007/089367

19 February 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Corrigenda Curis, Inc. and Genentech, Inc., Application No. 2006337085, under INID(54), correct the title to read Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.